APA (7th ed.) Citation

Lee, Y. B., Miranda, C. J., Allison, J., Kaliszewska, A., Bekele, Y., Hosseini, P., . . . Shaw, C. E. (2024). Pre‐clinical development of AVB‐101, an AAV gene therapy treatment for frontotemporal dementia with progranulin mutations. Alzheimer's & dementia: the journal of the Alzheimer's Association, 20(S1), 1. https://doi.org/10.1002/alz.086546

Chicago Style (17th ed.) Citation

Lee, Youn Bok, et al. "Pre‐clinical Development of AVB‐101, an AAV Gene Therapy Treatment for Frontotemporal Dementia with Progranulin Mutations." Alzheimer's & Dementia: The Journal of the Alzheimer's Association 20, no. S1 (2024): 1. https://doi.org/10.1002/alz.086546.

MLA (9th ed.) Citation

Lee, Youn Bok, et al. "Pre‐clinical Development of AVB‐101, an AAV Gene Therapy Treatment for Frontotemporal Dementia with Progranulin Mutations." Alzheimer's & Dementia: The Journal of the Alzheimer's Association, vol. 20, no. S1, 2024, p. 1, https://doi.org/10.1002/alz.086546.